AUD5.35
0.37% yesterday
Australia, Jun 13, 08:10 am CET
ISIN
AU0000013559
Symbol
ALX

Atlas Arteria Target price 2025 - Analyst rating & recommendation

Atlas Arteria Classifications & Recommendation:

Buy
20%
Hold
60%
Sell
20%

Atlas Arteria Price Target

Target Price AUD5.54
Price AUD5.35
Potential
Number of Estimates 8
8 Analysts have issued a price target Atlas Arteria 2026 . The average Atlas Arteria target price is AUD5.54. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 2 Analysts recommend Atlas Arteria to buy, 6 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Atlas Arteria stock has an average upside potential 2026 of . Most analysts recommend the Atlas Arteria stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million AUD 145.90 192.42
8.88% 31.88%
EBITDA Margin 43.39% 42.71%
9.30% 1.56%
Net Margin 188.69% 111.98%
1.35% 40.65%

6 Analysts have issued a sales forecast Atlas Arteria 2025 . The average Atlas Arteria sales estimate is

AUD192m
Unlock
. This is
31.88% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD376m 157.92%
Unlock
, the lowest is
AUD147m 0.45%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD146m 8.88%
2025
AUD192m 31.88%
Unlock
2026
AUD200m 4.02%
Unlock
2027
AUD216m 7.67%
Unlock
2028
AUD176m 18.47%
Unlock
2029
AUD184m 4.46%
Unlock

4 Analysts have issued an Atlas Arteria EBITDA forecast 2025. The average Atlas Arteria EBITDA estimate is

AUD82.2m
Unlock
. This is
29.82% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD111m 75.36%
Unlock
, the lowest is
AUD64.6m 2.01%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD63.3m 1.25%
2025
AUD82.2m 29.82%
Unlock
2026
AUD88.4m 7.63%
Unlock
2027
AUD95.2m 7.64%
Unlock
2028
AUD97.5m 2.42%
Unlock
2029
AUD103m 5.82%
Unlock

EBITDA Margin

2024 43.39% 9.30%
2025
42.71% 1.56%
Unlock
2026
44.19% 3.47%
Unlock
2027
44.17% 0.05%
Unlock
2028
55.49% 25.63%
Unlock
2029
56.21% 1.30%
Unlock

2 Atlas Arteria Analysts have issued a net profit forecast 2025. The average Atlas Arteria net profit estimate is

AUD215m
Unlock
. This is
21.73% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD261m 5.14%
Unlock
, the lowest is
AUD170m 38.33%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD275m 7.41%
2025
AUD215m 21.73%
Unlock
2026
AUD263m 21.85%
Unlock
2027
AUD295m 12.18%
Unlock
2028
AUD327m 11.05%
Unlock
2029
AUD368m 12.57%
Unlock

Net Margin

2024 188.69% 1.35%
2025
111.98% 40.65%
Unlock
2026
131.18% 17.15%
Unlock
2027
136.66% 4.18%
Unlock
2028
186.16% 36.22%
Unlock
2029
200.61% 7.76%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share AUD 0.19 0.15
5.56% 21.05%
P/E 36.16
EV/Sales 48.27

2 Analysts have issued a Atlas Arteria forecast for earnings per share. The average Atlas Arteria EPS is

AUD0.15
Unlock
. This is
21.05% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
AUD0.18 5.26%
Unlock
, the lowest is
AUD0.12 36.84%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD0.19 5.56%
2025
AUD0.15 21.05%
Unlock
2026
AUD0.18 20.00%
Unlock
2027
AUD0.20 11.11%
Unlock
2028
AUD0.23 15.00%
Unlock
2029
AUD0.25 8.70%
Unlock

P/E ratio

Current 28.29 7.31%
2025
36.16 27.82%
Unlock
2026
29.67 17.95%
Unlock
2027
26.45 10.85%
Unlock
2028
23.82 9.94%
Unlock
2029
21.16 11.17%
Unlock

Based on analysts' sales estimates for 2025, the Atlas Arteria stock is valued at an EV/Sales of

48.27
Unlock
and an P/S ratio of
40.49
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 63.66 7.63%
2025
48.27 24.18%
Unlock
2026
46.40 3.87%
Unlock
2027
43.10 7.12%
Unlock
2028
52.86 22.66%
Unlock
2029
50.60 4.27%
Unlock

P/S ratio

Current 53.40 8.50%
2025
40.49 24.18%
Unlock
2026
38.92 3.87%
Unlock
2027
36.15 7.12%
Unlock
2028
44.34 22.66%
Unlock
2029
42.45 4.27%
Unlock

Current Atlas Arteria Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
E&P
Locked
Locked
Locked Feb 26 2025
JEFFERIES
Locked
Locked
Locked Feb 26 2025
Analyst Rating Date
Locked
E&P:
Locked
Locked
Feb 26 2025
Locked
JEFFERIES:
Locked
Locked
Feb 26 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today